Study on changes in Cannabis-related substances in blood after herbal medicine with Cannabis Seeds

Assessment of THC and CBD in blood after consumption of Cannabis Semen-included prescription

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011073

Enrollment

Registered

2025-09-26

Start date

2025-10-01

Completion date

Unknown

Last updated

2025-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : 1. Name: Kyoungbang Majainhwan 1-1) Ingredients/Content (mg): Armeniacae Semen 426, Cannabis Semen 840, Magnoliae Cortex 342, Paeoniae Radix 342, Aurantii Fructus Immaturus 342, Rhei Radix et R

no separate intervention groups

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adults aged 19 to 65 years 2. Individuals who meet the Rome IV diagnostic criteria for functional constipation 3. Individuals who meet the above criteria, have received a detailed explanation of this clinical study, fully understood it, voluntarily decided to participate, and provided written informed consent to comply with study requirements

Exclusion criteria

Exclusion criteria: 1. Individuals who do not meet the age criteria (19–65 years) 2. Individuals who have undergone gastrointestinal surgery within the past 6 months 3. Individuals with gastrointestinal bleeding, obstructive lesions, or open abdominal wounds 4. Individuals with a history of severe respiratory, cardiovascular, renal, gastrointestinal, hepatic, endocrine, hematologic, neurological (including motor disorders), psychiatric disease, or other chronic conditions, as well as alcohol or drug dependence 5. Individuals who have participated in another clinical trial of an investigational drug or marketed product within 60 days prior to study initiation 6. Individuals with a history of significant adverse reactions such as hypersensitivity to investigational drugs 7. Women who are pregnant or breastfeeding

Design outcomes

Secondary

Measure	Time frame
Serum concentrations of Aspartate Transaminase (AST);Serum concentrations of Alanine Transaminase (ALT);Serum concentrations of Alkaline Phosphatase (ALP);Serum concentrations of Blood Urea Nitrogen;Serum concentrations of Creatinine	—

Primary

Measure	Time frame
Serum concentrations of delta-9 Tetrahydrocannabinol (THC);Serum concentrations of Cannabidiol (CBD)	—

Countries

Korea, Republic of

Contacts

Public ContactDasol Park

Wonkwang University

mare927@naver.com+82-63-850-6914

Outcome results